insights_auto
Why is HNSA up 4,33%?
Dive Deeperchevron_right
HNSA:STO
Hansa Biopharma AB
46,70 SEK
arrow_upward
+4,33%(+1,94) 1D
12-ноя., 09:21:58 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HNSA...
Open
44,90 SEK
High
46,96 SEK
Low
44,66 SEK
Mkt. cap
4,75 млд
Avg. vol.
547,22 миң
Volume
256,62 миң
52-wk high
48,22 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 млн
No. of employees
131
Open
44,90 SEK
High
46,96 SEK
Low
44,66 SEK
Mkt. cap
4,75 млд
Avg. vol.
547,22 миң
Volume
256,62 миң
52-wk high
48,22 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 млн
No. of employees
131
News stories
From web sources and news partners
GuruFocus
·
6 саат мурун
Hansa Biopharma AB (HNSBF) (Q3 2026) Earnings Call Highlights: C
Investing.com
·
18 саат мурун
Earnings call transcript: Hansa Biopharma Q3 2026 loss misses forecast as stock rises
Yahoo Finance
·
1 күн мурун
Hansa Biopharma Reports Third Quarter and Interim Year to Date 2026 Financial Results
TradingView
·
1 күн мурун
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees131
Founded2007
Headquarters-
SectorHealth Care
Industry-
Websitehansabiopharma.com